Related Experiment Video
Updated: Dec 22, 2025

Author Spotlight: Manipulating Signaling in Zebrafish Embryos to Decode Cell Fate Decisions
Published on: October 27, 2023
Arresting Developments in Biased Signaling
Sungsoo M Yoo1, Anshul Bhardwaj1, Jeffrey L Benovic1
1Department of Biochemistry and Molecular Biology, Thomas Jefferson University, Philadelphia, PA 19107, USA.
Abstract:
The ability to design 'biased' drugs that selectively activate G protein-coupled receptor (GPCR) signaling pathways beneficial in treating a disease, while limiting their side effects, is of broad significance. Lee et al. move us a step closer to this important goal by identifying structural differences in the β1-adrenoceptor in complex with β-arrestin 1 versus a G protein-mimicking nanobody.
Related Concept Videos
Understanding Deception
Stereotype Threat and Self-fulfilling Prophecies
Amplifying Signals via Enzymatic Cascade
Bias
In statistics, a sampling bias is created when a sample is collected from a population, and some members of the population are not as likely to be chosen as others (remember, each member...
Confirmation Biases
Assembly of Signaling Complexes
Interaction domains in cell signaling
Interaction domains recognize exposed features of their binding partners containing post-translationally modified sequences,...

